
Bruce Samuels presents Precision PCI


Highlighted event
PRECISION PCIYou are invited to a deep-dive live online course on coronary imaging, physiology, and techniques of complex PCI. The agenda includes lectures from US and international experts, case examples, a live case transmission from St. Francis Hospital, and virtual audience interaction opportunities. This program is designed for interventional cardiologists and is complimentary to attend.
- 19 Mar
- 10:45 am America/New_York
- 5H 25M
PRECISION PCI - 19th March 2021
View all

Bruce Samuels presents Precision PCI
Why Resting Physiology Assessment Works: Basics of Coronary Physiology

Bruce Samuels presents Precision PCI
Getting the Most Out of IVUS imaging: Basic Image Interpretation & Stent Sizing

Bruce Samuels presents Precision PCI
State of the Art Imaging; Detection of vulnerable plaque

Bruce Samuels presents Precision PCI
Assessment of Serial Lesions/Diffuse Disease with Angiographic Co-Registration

Bruce Samuels presents Precision PCI
Latest and Greatest: Emerging Trials in the Use of Physiology to Guide PCI vs. Medical Therapy

Bruce Samuels presents Precision PCI
IVUS for All: Making the Case for Routine Use of IVUS in PCI

Bruce Samuels presents Precision PCI
Live Case from St. Francis Hospital in New York

Bruce Samuels presents Precision PCI
Left Main PCI: The Need for IVUS to Obtain Optimal Results

Bruce Samuels presents Precision PCI
IVUS When You Need It Most: Calcium, Renal Failure and Other Concerns

Bruce Samuels presents Precision PCI
Physiology Assessment Without a Wire: Angio FFR and CT FFR

Bruce Samuels presents Precision PCI
IVUS Saved the Day: Case Reviews

Bruce Samuels presents Precision PCI
Check Your Work: Is Post PCI Physiology Mandatory?

Bruce Samuels presents Precision PCI
IVUS Determinants of Stent Thrombosis and Impact on DAPT Strategy

Bruce Samuels presents Precision PCI
Microvascular Physiology, Flow Based Coronary Assessment
Course director

Dr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center (CSMC) in Los Angeles, California. Dr. Samuels completed his medical studies at Albert Einstein College of Medicine in New York before returning to Southern California to complete his residency and chief residency in Internal Medicine at Harbor-UCLA Medical Center. At CSMC, he trained in both general and interventional cardiology before joining the medical staff there. In addition to his clinical practice in coronary intervention, Dr. Samuels has actively participated in numerous interventional trials including IVUS guided therapy, coronary physiology and microvascular disease. He is also working closely with the Barbra Streisand Women’s Heart Center based at CSMC, working as an interventionalist in the active coronary reactivity research there. As co-chair of a 30-day readmissions task force, he has helped to shape policy for CSMC in its efforts to improve quality delivery of care. He has frequently been invited as faculty to many scientific meetings and is a sought after speaker for numerous peer educational platforms. Dr. Samuels is a fellow of the American College of Cardiology and is Board Certified in Internal Medicine, Cardiovascular Diseases, and Interventional Cardiology. He is married with three sons; his outside interests include contemporary art and long distance running.
Course co-directors
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.

Paul Teirstein, MD, is the Chief of Cardiology and Director of Interventional Cardiology for Scripps Clinic and Director of the Scripps Prebys Cardiovascular Institute for Scripps Health. With a primary focus on complex coronary interventions and new technology development, Dr. Teirstein has played an active role in the initial development and clinical investigation of coronary stent procedures, rotablator atherectomy, coronary angioscopy and the utilization of cardiopulmonary support. Dr. Teirstein pioneered the first effective treatment for restenosis (low dose radiation therapy) and was one of the early investigators of medicated and bioabsorbable stents. Recent areas of investigation include new technology for minimally invasive transcatheter aortic valve replacement (TAVR). Dr. Teirstein currently performs in excess of 800 stent procedures per year and maintains an active clinical research and teaching unit at Scripps Clinic where he strives to offer patients the most advanced cardiovascular care available worldwide.
Popular videos featuring Bruce Samuels
View all

Simple Education
101 best reason to NOT use coronary physiology and imaging

CRT
INOCA Endotypes Diagnostic Criteria

CRT
Resting Versus Hyperemic Discordance

OPCI
Maximize stent size for best results: EEL-based sizing is superior

CRT
Understanding Ischemia with Non-Obstructive Coronary Artery Disease (INOCA)

CRT
Is QFR ready for primetime?